(CIDRAP News) – The first of two controversial H5N1 avian influenza studies to see print suggests that just four mutations in one of the virus's surface proteins may be enough to equip it to spread among mammals, but the findings are freighted with qualifiers.
(CIDRAP News) In the influenza literature, it's a given that ferrets are the best animal model for influenza in humans. They show similar clinical signs of disease, such as fever, coughing, and sneezing, and flu viruses that spread among humans usually spread in ferrets as well.
(CIDRAP News) A group of international donors who met yesterday in the final session of an avian influenza conference in Sharm el-Sheikh, Egypt, pledged more support for avian and pandemic flu preparedness and prevention, led by $320 million from the United States.
(CIDRAP News) David Nabarro, influenza coordinator for the United Nations (UN), said during a press conference yesterday that the world is better prepared to respond to an influenza pandemic, but he added that continuing outbreaks in some countries are a reminder that a major threat remains.
(CIDRAP News) Many countries have improved their responses to H5N1 avian influenza outbreaks in poultry in the past year, but the disease remains entrenched in six countries, according to a new report from the United Nations and the World Bank.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
Editor's note: This is the third in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.